746 related articles for article (PubMed ID: 27555126)
1. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
[TBL] [Abstract][Full Text] [Related]
3. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
4. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
[TBL] [Abstract][Full Text] [Related]
5. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study.
Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F
Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182
[TBL] [Abstract][Full Text] [Related]
6. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
Suzuki T; Kitajima O; Ueda K; Kondo Y; Kato J; Ogawa S
Br J Anaesth; 2011 Jun; 106(6):823-6. PubMed ID: 21531745
[TBL] [Abstract][Full Text] [Related]
8. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
9. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
11. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
Gaszynski T; Szewczyk T; Gaszynski W
Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
[TBL] [Abstract][Full Text] [Related]
13. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
16. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
[TBL] [Abstract][Full Text] [Related]
17. Monitoring recovery from rocuronium-induced neuromuscular block using acceleromyography at the trapezius versus the adductor pollicis muscle: an observational trial.
Soltesz S; Stark C; Noé KG; Anapolski M; Mencke T
Can J Anaesth; 2016 Jun; 63(6):709-17. PubMed ID: 26864194
[TBL] [Abstract][Full Text] [Related]
18. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
19. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
[TBL] [Abstract][Full Text] [Related]
20. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
